Analyst optimistic about NZX-listed cancer-test maker

Broker Forsyth Barr has released the first comprehensive report into Dunedin-based biotech company Pacific Edge [NZX: PEB], and its outlook is positive, pleasing one investor Aaron Bhatnagar.

The New Zealand maker of non-invasive bladder cancer test kits Cxbladder has just launched a local online ordering service and has high hopes to dominate the US market.


Want to read more?

Choose a Subscription type that's right for you HERE
Already have an account? Login